Blotting Systems

Blotting Systems

Global Blotting Systems Market to Reach US$1.6 Billion by 2030

The global market for Blotting Systems estimated at US$1.1 Billion in the year 2023, is expected to reach US$1.6 Billion by 2030, growing at a CAGR of 5.4% over the analysis period 2023-2030. Pharma & Biotech Companies End-Use, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$776.2 Million by the end of the analysis period. Growth in the Academic & Research Institutes End-Use segment is estimated at 5.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$297.5 Million While China is Forecast to Grow at 8.5% CAGR

The Blotting Systems market in the U.S. is estimated at US$297.5 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$379.2 Million by the year 2030 trailing a CAGR of 8.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.1% and 4.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Blotting Systems Market - Key Trends and Drivers Summarized

Why Are Blotting Systems Integral to Molecular Biology Research?

Blotting systems are fundamental tools in molecular biology, playing a critical role in the detection and analysis of biomolecules such as DNA, RNA, and proteins. Techniques like Western blotting, Southern blotting, and Northern blotting enable researchers to transfer and immobilize nucleic acids or proteins onto a membrane for further analysis, allowing for the identification, quantification, and characterization of specific molecules within a complex mixture. These systems are indispensable in various applications, including genetic research, diagnostics, and drug development, where precise molecular analysis is crucial. The ability of blotting systems to detect low-abundance molecules with high specificity and sensitivity makes them invaluable for researchers seeking to understand the molecular underpinnings of diseases and develop targeted therapies.

How Are Technological Advancements Shaping the Future of Blotting Systems?

The field of blotting systems is evolving rapidly, driven by technological advancements that are enhancing the efficiency, sensitivity, and throughput of these techniques. Innovations such as automated blotting systems are streamlining the blotting process, reducing manual labor and minimizing errors, which is particularly beneficial in high-throughput laboratories. The development of enhanced chemiluminescence and fluorescence detection methods has significantly improved the sensitivity of blotting assays, enabling the detection of even minute quantities of target molecules. Additionally, the integration of digital imaging and analysis software is providing researchers with more accurate and reproducible data, facilitating better interpretation of results. These technological improvements are making blotting systems more accessible and effective, thereby expanding their applications in both research and clinical settings.

What Challenges and Market Dynamics Are Influencing the Blotting Systems Industry?

The blotting systems market is influenced by a range of challenges and dynamic market forces. One of the key challenges is the need for systems that can deliver high sensitivity and specificity while being cost-effective and easy to use. This has driven companies to invest in the development of more robust and user-friendly systems that can meet the diverse needs of researchers across different fields. Another significant challenge is the competition from alternative technologies, such as mass spectrometry and next-generation sequencing, which offer high-throughput and multiplexing capabilities. Despite these challenges, blotting systems remain a staple in molecular biology due to their established protocols, versatility, and the deep-rooted familiarity of these techniques among researchers. Market dynamics are also shaped by the growing demand for personalized medicine and the need for precise molecular diagnostics, which continue to drive the adoption of advanced blotting technologies.

What Factors Are Driving the Growth of the Blotting Systems Market?

The growth in the blotting systems market is driven by several factors, including the increasing demand for proteomics and genomics research, which relies heavily on blotting techniques for the analysis of proteins and nucleic acids. The expanding scope of biomedical research, particularly in the fields of cancer, infectious diseases, and genetic disorders, is also fueling the need for advanced blotting systems that can provide detailed molecular insights. Additionally, the rise of personalized medicine, which requires precise molecular characterization of patient samples, is driving the adoption of more sophisticated blotting technologies. Technological advancements, such as the development of high-sensitivity detection methods and automated systems, are further propelling market growth by making blotting assays more efficient and accessible to a broader range of laboratories. Moreover, the increasing emphasis on reproducibility and accuracy in scientific research is enhancing the demand for high-quality blotting systems that can deliver reliable results. As research continues to push the boundaries of molecular biology, the need for advanced and versatile blotting systems is expected to grow, driving further innovation and expansion in the market.

Select Competitors (Total 44 Featured) -
  • Advansta Inc.
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Coporation
  • Cell Signaling Technology, Inc.
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • LI-COR, Inc. (LI-COR Biosciences)
  • Merck KgaA
  • PerkinElmer, Inc.
  • Thermo Fisher Scientific, Inc.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Blotting Systems – Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Increasing Demand for Protein Analysis Propels Growth of Blotting Systems
Advancements in Imaging Technologies Drive Adoption of Automated Blotting Systems
Rising Research in Proteomics Expands the Addressable Market Opportunity
Shift Towards High-Throughput Blotting Systems Strengthens the Business Case for Innovation
Growing Focus on Precision Medicine Throws the Spotlight on Advanced Blotting Techniques
Rising Incidence of Chronic Diseases Spurs Demand for Reliable Diagnostic Tools
Here`s the Story: How Automation in Laboratories Drives Adoption of Blotting Systems
Integration of Blotting Systems with Digital Platforms Generates Competitive Advantages
Here`s How Environmental and Food Safety Testing Spurs the Need for Efficient Blotting Systems
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Blotting Systems Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Blotting Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 3: World Historic Review for Blotting Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 4: World 16-Year Perspective for Blotting Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 6: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 7: World 16-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 9: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 10: World 16-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Hospitals & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 12: World Historic Review for Hospitals & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 13: World 16-Year Perspective for Hospitals & Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 14: USA Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 15: USA Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 16: USA 16-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2014, 2024 & 2030
CANADA
TABLE 17: Canada Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 18: Canada Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 19: Canada 16-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2014, 2024 & 2030
JAPAN
Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 20: Japan Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 21: Japan Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 22: Japan 16-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2014, 2024 & 2030
CHINA
Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 23: China Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 24: China Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 25: China 16-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2014, 2024 & 2030
EUROPE
Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 26: Europe Recent Past, Current & Future Analysis for Blotting Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 27: Europe Historic Review for Blotting Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 28: Europe 16-Year Perspective for Blotting Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 29: Europe Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 30: Europe Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 31: Europe 16-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2014, 2024 & 2030
FRANCE
Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 32: France Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 33: France Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 34: France 16-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2014, 2024 & 2030
GERMANY
Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 35: Germany Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 36: Germany Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 37: Germany 16-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2014, 2024 & 2030
ITALY
TABLE 38: Italy Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 39: Italy Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 40: Italy 16-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2014, 2024 & 2030
UNITED KINGDOM
Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 41: UK Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 42: UK Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 43: UK 16-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2014, 2024 & 2030
SPAIN
TABLE 44: Spain Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 45: Spain Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 46: Spain 16-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2014, 2024 & 2030
RUSSIA
TABLE 47: Russia Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 48: Russia Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 49: Russia 16-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 51: Rest of Europe Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 52: Rest of Europe 16-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Blotting Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 54: Asia-Pacific Historic Review for Blotting Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 55: Asia-Pacific 16-Year Perspective for Blotting Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 57: Asia-Pacific Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 58: Asia-Pacific 16-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2014, 2024 & 2030
AUSTRALIA
Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
TABLE 59: Australia Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 60: Australia Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 61: Australia 16-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2014, 2024 & 2030
INDIA
Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
TABLE 62: India Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 63: India Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 64: India 16-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2014, 2024 & 2030
SOUTH KOREA
TABLE 65: South Korea Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 66: South Korea Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 67: South Korea 16-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 69: Rest of Asia-Pacific Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 70: Rest of Asia-Pacific 16-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2014, 2024 & 2030
LATIN AMERICA
Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 71: Latin America Recent Past, Current & Future Analysis for Blotting Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 72: Latin America Historic Review for Blotting Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 73: Latin America 16-Year Perspective for Blotting Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
TABLE 74: Latin America Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 75: Latin America Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 76: Latin America 16-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2014, 2024 & 2030
ARGENTINA
TABLE 77: Argentina Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 78: Argentina Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 79: Argentina 16-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2014, 2024 & 2030
BRAZIL
TABLE 80: Brazil Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 81: Brazil Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 82: Brazil 16-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2014, 2024 & 2030
MEXICO
TABLE 83: Mexico Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 84: Mexico Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 85: Mexico 16-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 87: Rest of Latin America Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 88: Rest of Latin America 16-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2014, 2024 & 2030
MIDDLE EAST
Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
TABLE 89: Middle East Recent Past, Current & Future Analysis for Blotting Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 90: Middle East Historic Review for Blotting Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 91: Middle East 16-Year Perspective for Blotting Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
TABLE 92: Middle East Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 93: Middle East Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 94: Middle East 16-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2014, 2024 & 2030
IRAN
TABLE 95: Iran Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 96: Iran Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 97: Iran 16-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2014, 2024 & 2030
ISRAEL
TABLE 98: Israel Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 99: Israel Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 100: Israel 16-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2014, 2024 & 2030
SAUDI ARABIA
TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 102: Saudi Arabia Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 103: Saudi Arabia 16-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
TABLE 104: UAE Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 105: UAE Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 106: UAE 16-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 108: Rest of Middle East Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 109: Rest of Middle East 16-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2014, 2024 & 2030
AFRICA
Blotting Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
TABLE 110: Africa Recent Past, Current & Future Analysis for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 111: Africa Historic Review for Blotting Systems by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 112: Africa 16-Year Perspective for Blotting Systems by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Laboratories for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings